Loading clinical trials...
Loading clinical trials...
This is a randomized, double blinded, phase 1 study. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single dose of VSA003 in healthy adult ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Visirna Therapeutics HK Limited
NCT07473960 · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT07037771 · Homozygous Familial Hypercholesterolemia
NCT07489209 · Homozygous Familial Hypercholesterolemia (HoFH)
NCT07058077 · Heterozygous Familial Hypercholesterolemia (HeFH)
NCT06331195 · Familial Hypercholesterolemia
Peking Union Medical College Hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions